Amgen Appoints Rebecca M. Henderson to the Company's Board of Directors
July 09 2009 - 5:42PM
PR Newswire (US)
THOUSAND OAKS, Calif., July 9 /PRNewswire-FirstCall/ -- Amgen
(NASDAQ: AMGN) announced today that its Board of Directors has
appointed Rebecca M. Henderson, Ph.D., to the Company's Board. Dr.
Henderson, 48, has recently joined the faculty at the Harvard
Business School, having been the Eastman Kodak LFM Professor of
Management at the Massachusetts Institute of Technology (MIT) Sloan
School since 1999. She specializes in technology strategy and the
broader strategic problems faced by firms in high technology
industries. From 1995 to 1999, Dr. Henderson was a tenured
associate professor at the MIT Sloan School. She has been a
director of IDEXX Laboratories, Inc. since 2003. Dr. Henderson's
appointment brings the number of Amgen Board members to 13. Dr.
Henderson will serve as a member of the Corporate Responsibility
and Compliance and Governance and Nominating Committees of the
Board. Dr. Henderson has also been a research associate at the
National Bureau of Economic Research since 1995. She also sits on
the editorial boards of Management Science, Research Policy and
Organization Science. About Amgen Amgen discovers, develops,
manufactures and delivers innovative human therapeutics. A
biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and
effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a deep and broad pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve
people's lives. To learn more about our pioneering science and our
vital medicines, visit http://www.amgen.com/. CONTACT: Amgen,
Thousand Oaks Mary Klem, 805-447-6979 (media) Arvind Sood,
805-447-1060 (investors) (Logo:
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO
http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: media, Mary
Klem, +1-805-447-6979, or investors, Arvind Sood, +1-805-447-1060,
both of Amgen, Thousand Oaks Web Site: http://www.amgen.com/
Copyright